Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Other Non-Current Liabilities of $1.2 million for Q4 2025, down 56.4% year-on-year from $2.8 million in Q4 2024, and down 56.4% on a QoQ basis from $2.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Other Non-Current Liabilities for 7 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 56.4% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 56.4% YoY) and the FY2025 annual result came in at $1.2 million, down 56.4% from the prior year.
  • Other Non-Current Liabilities eased to $1.2 million in Q4 2025 per CURLF's latest filing, from $2.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CURLF reached as high as $6.6 billion in Q1 2022 and fell as low as $298000.0 in Q3 2023.
  • A 5-year average of $457.6 million and a median of $4.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 348055.95% — and 2023, when it slumped 96.99%.
  • Year by year, Other Non-Current Liabilities stood at $38.0 million in 2021, then dropped by 23.38% to $29.1 million in 2022, then tumbled by 83.77% to $4.7 million in 2023, then slumped by 39.94% to $2.8 million in 2024, then plunged by 56.4% to $1.2 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.2 million, $2.8 million, and $3.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.24 Mn
Dec 31, 2024 2.84 Mn
Sep 30, 2024 3.69 Mn
Jun 30, 2024 3.50 Mn
Dec 31, 2023 4.72 Mn
Sep 30, 2023 298,000.00
Jun 30, 2023 103.69 Mn
Dec 31, 2022 29.11 Mn
Sep 30, 2022 9.89 Mn
Jun 30, 2022 1.87 Mn
Mar 31, 2022 6.61 Bn
Dec 31, 2021 37.99 Mn
Sep 30, 2021 26.15 Mn
Jun 30, 2021 29.11 Mn
Mar 31, 2021 1.90 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 41.23 Mn
Dec 31, 2019 32.62 Mn